Stimulation of the apoptotic response as a basis for the therapeutic synergism of lonidamine and cisplatin in combination in human tumour xenografts.
Open Access
- 1 February 1998
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 77 (3) , 434-439
- https://doi.org/10.1038/bjc.1998.69
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Doxorubicin disaccharide analogue: apoptosis-related improvement of efficacy in vivo.JNCI Journal of the National Cancer Institute, 1997
- Apoptosis as a determinant of tumor sensitivity to topotecan in human ovarian tumors: preclinical in vitro/in vivo studies.1997
- Lonidamine induces apoptosis in drug-resistant cells independently of the p53 gene.Journal of Clinical Investigation, 1996
- Efficacy of lonidamine combined with different DNA-damaging agents in the treatment of the MX-1 tumor xenograftCancer Chemotherapy and Pharmacology, 1996
- Inactivation of Bcl-2 by phosphorylation.Proceedings of the National Academy of Sciences, 1995
- Lonidamine-mediated respiratory changes in rat heart myocytes: A re-examination of the functional response of mitochondrial cytochrome c oxidaseBiochemical Pharmacology, 1994
- Apoptosis. Its significance in cancer and cancer TherapyCancer, 1994
- Bcl-2 and the regulation of programmed cell deathThe Journal of cell biology, 1994
- Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.The Journal of cell biology, 1992
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970